IP Library Granted Patent US 11,690,802
Granted Patent B2
US 11,690,802 · App. 17/200,043 · Granted Jul 4, 2023

Ophthalmic emulsion

Inventors: Howard Allen Ketelson (Dallas, TX); David L. Meadows (Colleyville, TX)
Assignee: Alcon Inc.
A61K9/107A61K9/0048C09K23/00C09K23/017C09K23/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,690,802
App. No.
17/200,043
Granted
Jul 4, 2023
Kind
B2
Abstract

The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.

Claims (20)

1. An ophthalmic emulsion, the emulsion comprising:

water forming an aqueous phase;

oil forming an oil phase, wherein the oil is at least 0.1 w/v % and not greater than 5 w/v % of the emulsion;

a hydrophilic surfactant having an HLB value of at least 8, wherein the hydrophilic surfactant is present in the emulsion in an amount that is at least 0.08 w/v % and no greater than 0.8 w/v %;

a hydrophobic surfactant having an HLB value of below 8, wherein the hydrophobic surfactant is present in the emulsion in an amount that is at least 0.11 w/v % and no greater than 2.0 w/v %;

an anionic phospholipid;

borate;

a mucoadhesive galactomannan polymer, wherein the mucoadhesive galactomannan polymer is present in the emulsion in a concentration of at least 0.01 w/v %, but no greater than 1.0 w/v %;

wherein the emulsion is free of a benzalkonium chloride,

wherein:

i. the oil phase is in droplets within the aqueous phase and the droplets have an average diameter that is no greater than about 1000 nm, but is at least 10 nm, wherein the average diameter is corresponding to 90% of the cumulative undersize distribution by volume measured using a Microtrac S3500 Particle Size Analyzer (Software Version 10.3.1); and

ii. the borate and galactomannan polymer cooperatively act to form a gel upon instillation of the emulsion in an eye of an individual.

2. The emulsion according to claim 1 wherein the oil is a hydrocarbon selected from mineral oil, paraffin oil and petrolatum.

3. The emulsion according to claim 1 wherein the hydrophilic surfactant is polyoxyethylene-40-stearate.

4. The emulsion according to claim 1 wherein the hydrophobic surfactant is a sorbitan tristearate.

5. The emulsion according to claim 1 wherein the mucoadhesive galactomannan polymer is selected from the group consisting of guar and hydroxypropyl guar.

6. The emulsion according to claim 1 wherein the anionic phospholipid is dimyristoyl phosphatidylglycerol.

7. The emulsion according to claim 1 wherein the phospholipid is present in the emulsion in a concentration from 0.05 to 7.0 percent by weight.

8. The emulsion according to claim 1 further comprising a borate/polyol buffer system.

9. The emulsion according to claim 1 wherein the oil phase is in droplets within the aqueous phase and the droplets have an average diameter that is no greater than 500 nm but is at least 100 nm, wherein the average diameter is corresponding to 90% of the cumulative undersize distribution by volume measured using a Microtrac S3500 Particle Size Analyzer (Software Version 10.3.1).

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: KETELSON, HOWARD ALLEN; MEADOWS, DAVID L.
To: ALCON RESEARCH, LTD.
Reel/Frame 055688/0460 →
MERGER Recorded Mar 23, 2021
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 055688/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 055688/0655 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 055688/0740 →
Continuity (7)
Continuation 16811461 · Mar 6, 2020
Continuation 16405180 · May 7, 2019
Continuation 15989383 · May 25, 2018
Continuation 15228589 · Aug 4, 2016
Continuation 12958763 · Dec 2, 2010
Provisional Application 61266207 · Dec 3, 2009
Related Publication 20210196628A1 · Jul 1, 2021
Cited By (1)
US 12,527,745